New Port Richey, FL1 Active Studies

Primary Biliary Cholangitis Clinical Trials in New Port Richey, FL

Find 1 actively recruiting primary biliary cholangitis clinical trials in New Port Richey, FL. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
260
Enrolling

Recruiting Primary Biliary Cholangitis Studies in New Port Richey

About Primary Biliary Cholangitis Clinical Trials in New Port Richey

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.

There are currently 1 primary biliary cholangitis clinical trials recruiting participants in New Port Richey, FL. These studies are seeking a combined 260 participants. Research is being sponsored by Mirum Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Primary Biliary Cholangitis Clinical Trials in New Port Richey — FAQ

Are there primary biliary cholangitis clinical trials in New Port Richey?

Yes, there are 1 primary biliary cholangitis clinical trials currently recruiting in New Port Richey, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in New Port Richey?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Port Richey research site will contact you about next steps.

Are clinical trials in New Port Richey free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Port Richey studies also compensate for your time and travel.

What primary biliary cholangitis treatments are being tested?

The 1 active trials in New Port Richey are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.

Data updated March 2, 2026 from ClinicalTrials.gov